If you are working in the field of drug discovery and want to learn step-by-step how to perform protein-ligand docking, then this free, 90-minute, hands-on workshop is for you!
In drug discovery, it is important to understand how a small molecule (ligand) and a protein will bind. Protein-ligand docking is a computational method to predict the configuration of such interactions and an important step during drug design.
Recent research indicates that the rate of global warming caused by human activity is at an all-time high.* In response, Pioneer Group, a specialist in life science infrastructure and venture building, is ramping up its support for start-up businesses tackling planetary health challenges.
This year, Pioneer is accelerating the development of planetary health innovations through a comprehensive programme of events, a “Golden Ticket” competition, venture development support, specialist lab space, and access to its expert network.
Are you a life sciences, healthtech or medtech company founder or C-Suite executive planning US market entry or expansion? Join us for an exclusive online workshop designed to equip you with the knowledge, connections, and strategies to thrive in the US market.
Date: Wednesday 25th or Thursday 26th September
Time: 1500-1900 BST (1-2-1 meeting slots available throughout)
Platform: Zoom (details to follow)
Key benefits:
Are you a life sciences, healthtech or medtech company founder or C-Suite executive planning US market entry or expansion? Join us for an exclusive online workshop designed to equip you with the knowledge, connections, and strategies to thrive in the US market.
Date: Wednesday 25th or Thursday 26th September
Time: 1500-1900 BST (1-2-1 meeting slots available throughout)
Platform: Zoom (details to follow)
Key benefits:
Guest blog post by Domainex
Domainex launches a new webinar series, hosted by One Nucleus, to discuss the latest approaches and technologies that will be vital in any drug discovery programme.
Following the boom-and-bust years of Covid investment followed by economic challenges, the UK life science industry is still driving progress in drug discovery. But with the cost of medicines development continuing to soar, staying one step ahead in this competitive space is an ongoing challenge.
We are pleased to announce a new Cambridge Proteomics and Mass Spectrometry (MS) Meeting will be held on Thursday 17th October at 12-5pm on the Babraham Research Campus. This meeting will feature talks, posters, and networking for both academics and companies in and around Cambridge.
Guest blog post by Domainex
Domainex launches a new webinar series, hosted by One Nucleus, to discuss the latest approaches and technologies that will be vital in any drug discovery programme.
Following the boom-and-bust years of Covid investment followed by economic challenges, the UK life science industry is still driving progress in drug discovery. But with the cost of medicines development continuing to soar, staying one step ahead in this competitive space is an ongoing challenge.
Clinical Science Liaison / Medical Affairs
– French and English-speaking
Location: Poland
Sandwich, Kent, UK / 24 September 2024 / A group of former Pfizer employees have successfully created their own businesses based at and supported by Discovery Park, a thriving life sciences community in Kent.
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.
The £3 million programme, funded by LifeArc, will support six early-stage novel antimicrobial projects over two years to accelerate new treatments for lung infections in people with CF.